Skip to main content
logo
Sirio Pharma Co., Ltd. (SHE:300791)
China flag China · Delayed Price · Currency is CNY
16.93
+0.19 (1.14%)
Oct 28, 2026, 10:54 AM CST

Sirio Pharma Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
106.13136.53325.06281.04212.29231.83
Depreciation & Amortization
233.75233.75239.27256.96131.74104.06
Other Amortization
96.2896.2849.176.084.642.54
Loss (Gain) From Sale of Assets
-2.43-2.43-0.24-0.035.34-0.16
Asset Writedown & Restructuring Costs
137.18137.184.410.950.17-0.56
Loss (Gain) From Sale of Investments
0.710.7128.9652.06-21.76-24.14
Stock-Based Compensation
12.8412.845.281.73-3.99-
Provision & Write-off of Bad Debts
4.354.350.325.063.990.96
Other Operating Activities
-50.8320.7229.92-8.2420.634.19
Change in Accounts Receivable
-1.02-1.02-57.38-125.21-75.05-75.34
Change in Inventory
-14.94-14.94-5.72-59.33.5622.89
Change in Accounts Payable
43.2443.2417.286.5782.148.93
Change in Other Net Operating Assets
-12.28-12.28-7.54-18.2468.3321.37
Operating Cash Flow
468.22570.18566.97386.08444.86341.38
Operating Cash Flow Growth
-32.68%0.57%46.85%-13.21%30.31%6.82%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-372.22-441.26-412.13-451.7-293.69-524.68
Sale of Property, Plant & Equipment
9.186.794.922.74-0.45
Cash Acquisitions
----707.54-21.63-
Divestitures
16.6-----
Investment in Securities
-123.94-9.06101-103.17680-238
Other Investing Activities
47.831.51-21.77101.82-80.7726.75
Investing Cash Flow
-422.55-442.01-327.98-1,158283.91-735.48

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Short-Term Debt Issued
-3.9610.11--1,016
Long-Term Debt Issued
-331.08271.4797.220.03-
Total Debt Issued
758.47335.03281.5997.220.031,016
Short-Term Debt Repaid
------31.95
Long-Term Debt Repaid
--333.3-186.11-17.42-9.42-6.16
Lease Payments
-47.35-47.35-37.49-17.27-9.42-6.16
Total Debt Repaid
-324.34-333.3-186.11-17.42-9.42-38.11
Net Debt Issued (Repaid)
434.141.7395.4879.8-9.38978.06
Issuance of Common Stock
19.3321.663.113.546.63.35
Repurchase of Common Stock
-5.65-5.65-9.8-31--
Common Dividends Paid
-80.35-183.03-219.63-83.83-76.09-72.53
Other Financing Activities
-77.97-2.52--69.660.97-2.76
Financing Cash Flow
289.49-167.82-130.84-91.15-77.9906.11

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
-16.220.442.5-4.5929.86-11.27
Net Cash Flow
318.94-39.21110.64-867.52680.72500.74

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
96128.92154.84-65.62151.17-183.31
Free Cash Flow Growth
-53.46%-16.74%----
Free Cash Flow Margin
2.38%3.02%3.68%-1.83%6.03%-7.74%
Free Cash Flow Per Share
0.320.420.51-0.210.49-0.57
Levered Free Cash Flow
-26.04110.316.37-211.1924.38-289.58
Unlevered Free Cash Flow
42.61174.5175.77-162.1451.11-280.87
Free Cash Flow After Leases
48.6581.57117.35-82.89141.75-189.47

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Income Tax Paid
84.52142.7567.1188.459.1685.05
Change in Working Capital
-69.75-69.75-115.17-209.5291.83-7.36